Hillstream Biopharma Stock Current Valuation
| HILSDelisted Stock | USD 0.39 0.01 2.50% |
Valuation analysis of Hillstream Biopharma helps investors to measure Hillstream Biopharma's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns.
Overvalued
Today
Please note that Hillstream Biopharma's price fluctuation is very steady at this time. Calculation of the real value of Hillstream Biopharma is based on 3 months time horizon. Increasing Hillstream Biopharma's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Hillstream stock is determined by what a typical buyer is willing to pay for full or partial control of Hillstream Biopharma. Since Hillstream Biopharma is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Hillstream Stock. However, Hillstream Biopharma's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.39 | Real 0.37 | Hype 0.39 |
The intrinsic value of Hillstream Biopharma's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Hillstream Biopharma's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Hillstream Biopharma helps investors to forecast how Hillstream stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Hillstream Biopharma more accurately as focusing exclusively on Hillstream Biopharma's fundamentals will not take into account other important factors: Hillstream Biopharma Company Current Valuation Analysis
Hillstream Biopharma's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Hillstream Biopharma Current Valuation | 496.66 K |
Most of Hillstream Biopharma's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Hillstream Biopharma is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
CompetitionIn accordance with the recently published financial statements, Hillstream Biopharma has a Current Valuation of 496.66 K. This is 100.0% lower than that of the Biotechnology sector and 99.99% lower than that of the Health Care industry. The current valuation for all United States stocks is 100.0% higher than that of the company.
Hillstream Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Hillstream Biopharma's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Hillstream Biopharma could also be used in its relative valuation, which is a method of valuing Hillstream Biopharma by comparing valuation metrics of similar companies.Hillstream Biopharma is currently under evaluation in current valuation category among its peers.
Hillstream Fundamentals
| Return On Equity | -1.47 | |||
| Return On Asset | -0.78 | |||
| Current Valuation | 496.66 K | |||
| Shares Outstanding | 17.53 M | |||
| Shares Owned By Insiders | 38.90 % | |||
| Shares Owned By Institutions | 0.80 % | |||
| Number Of Shares Shorted | 52.74 K | |||
| Price To Book | 0.88 X | |||
| EBITDA | (6.88 M) | |||
| Net Income | (8.47 M) | |||
| Cash And Equivalents | 9.48 M | |||
| Cash Per Share | 0.82 X | |||
| Total Debt | 772.9 K | |||
| Current Ratio | 13.13 X | |||
| Book Value Per Share | 0.18 X | |||
| Cash Flow From Operations | (6.56 M) | |||
| Short Ratio | 0.20 X | |||
| Earnings Per Share | (0.76) X | |||
| Target Price | 4.0 | |||
| Market Capitalization | 4.23 M | |||
| Total Asset | 6.69 M | |||
| Retained Earnings | (15.38 M) | |||
| Working Capital | 5.54 M | |||
| Z Score | -2.34 | |||
| Net Asset | 6.69 M |
About Hillstream Biopharma Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Hillstream Biopharma's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Hillstream Biopharma using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Hillstream Biopharma based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.
Other Consideration for investing in Hillstream Stock
If you are still planning to invest in Hillstream Biopharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Hillstream Biopharma's history and understand the potential risks before investing.
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios |